Grifols Educational Resources
Grifols is dedicated to providing high-quality educational resources to support transfusion medicine professionals worldwide. Explore Grifols’ resources and stay updated on the latest in transfusion medicine.
A world of safe and sufficient blood is a team effort. Corporate Partners demonstrate a high level of commitment to our vision through financial support and efforts to raise awareness.
We work together with like-minded companies to share knowledge to enhance transfusion practice, and we thank them for their support:
Roche provides diagnostic tests and automation platforms used worldwide to improve the safety of blood products, increase laboratory efficiency, diagnose disease, monitor response to therapy and identify gene-based factors that may aid in treatment selection.
For more information on Roche Blood Safety Solutions, please visit the Donor Screening section of our website using the link below.
Abbott is a globally diversified healthcare company with a central purpose to help people live their healthiest possible lives. From removing the regular pain of fingersticks as people manage their diabetes to connecting patients to doctors with real-time information monitoring their hearts, from easing chronic pain and movement disorders to testing half the world’s blood donations to ensure a healthy supply, our purpose is to make the world a better place by bringing life-changing health technologies to the people who need them. That’s our commitment to helping you live your best life.
Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. They accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.
Terumo Blood cells and technologies is a medical technology company. Their products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Terumo BCT employees around the world believe in the potential of blood and cells to do even more for patients than they do today.
Founded in 1977 in the North area of France, Macopharma is a major player in blood industry. Its development has always been driven by important innovations resulting from significant investments in research and development and collaborations developed with customers and partners.
Macopharma offers a range of blood processing solutions combining expertise on disposables, equipments, softwares and processing guidelines to support healthcare professionals for safer and higher quality blood components for the benefit of donors and patients.
The single focus of Fresenius Kabi TCT is to enable our Transfusion Medicine and Cell Therapies (TCT) customers to achieve their mission around the world. We are global leaders in apheresis technology for both blood component collection and extracorporeal therapies, bringing new innovations focused on donor and patient comfort. Our expert team is dedicated to forming deep partnerships with our customers, listening to their needs and responding with innovative thinking, collaboration and a shared commitment to the donors and patients we both serve.
Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development.
DIAGAST’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable.
Over the last 30 years, DIAGAST has developed unparalleled expertise and know-how in the transfusion sector. DIAGAST develops, manufactures and markets reagents (for blood group determination), miniaturized laboratories for manual analysis and automated systems.
Snibe has been focused on the IVD field for 29 years and is also the first Chinese manufacturer of chemiluminescence immunoassays to get FDA clearance. At present, Snibe has 3 main product lines of chemiluminescence immunoassay, clinical chemistry and molecular diagnosis. Now Snibe's products have covered more than 152 countries globally with installations of over 30000 units. Furthermore, Snibe offers one of the broadest chemiluminescence immunoassay test menus, with 211 parameters including tests for thyroid function, fertility, infectious diseases, tumor markers, and others.
Haier Biomedical was founded to focus on design, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. Using the concept of IoT, the company has become a provider of comprehensive solutions for various biotechnological challenges. Operating globally, Haier Biomedical, the world’s only complete cold chain provider, has storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
The company tackles new national and international challenges and meets high demands on blood supply management and vaccine safety, designing and implementing intelligent global networks and safe solutions for IoT-based blood management systems and vaccinations.
Haier’s low-temperature equipment and sample management systems have been installed in over five-hundred bio-storage banks in China. The company has significantly contributed to the advancement of China’s biological technology and research.
Haier Biomedical successfully creates a new synergy by combining it’s manufacturing with IoT-based biological and medical sciences and practices. The company is the driving force of innovation in product design and application. Its low-temperature storage equipment works with IoT-based technology to make it possible for product real-time monitoring and tracking, intelligent vaccination, and precise blood management. Haier Biomedical leads a new revolution in traditional manufacturing as well as innovative technology development.
Explore transfusion medicine learning opportunities from our Platinum and Gold Corporate Partners.
ISBT collaborates with leading industry partners to advance education in transfusion medicine. Below, you’ll find links to educational resources from our Platinum and Gold Corporate Partners, offering expert insights, training, and research updates.